ZURA BIO LIMITED Other Nonoperating Income
ZURA BIO LIMITED (ZURA) reported Other Nonoperating Income of $260.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncome · last filed 2026-03-19
- ZURA BIO LIMITED other nonoperating income for the quarter ending 2023-06-30 was $412.00K, a 20500.00% increase year-over-year.
- ZURA BIO LIMITED other nonoperating income for the quarter ending 2022-06-30 was $2.00K.
- ZURA BIO LIMITED other nonoperating income for fiscal 2025 was $260.00K, a 828.57% increase from fiscal 2024.
- ZURA BIO LIMITED other nonoperating income for fiscal 2024 was $28.00K, a 64.71% increase from fiscal 2023.
- ZURA BIO LIMITED other nonoperating income for fiscal 2023 was $17.00K.
| Period end | Other Nonoperating Income 3 month | Other Nonoperating Income 5 month | Other Nonoperating Income 6 month | Other Nonoperating Income 12 month |
|---|---|---|---|---|
| 2025-12-31 | $260.00K 10-K · filed 2026-03-19 | |||
| 2024-12-31 | $28.00K 10-K · filed 2026-03-19 | |||
| 2023-12-31 | $17.00K 10-K · filed 2025-03-25 | |||
| 2023-06-30 | $412.00K 10-Q · filed 2023-08-14 | $403.00K 10-Q · filed 2023-08-14 | ||
| 2022-06-30 | $2.00K 10-Q · filed 2023-08-14 | $2.00K 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |